Want to see GB:DXRX full AI Analyst Report?
Diaceutics (DXRX) Financial Statements
Diaceutics Financial Overview
Diaceutics's market cap is currently $172.63M. The company's EPS TTM is $-0.00; its P/E ratio is -635.94; Diaceutics is scheduled to report earnings on March 15, 2027, and the estimated EPS forecast is $0.03. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 38.44M | $ 32.16M | $ 23.70M | $ 19.50M | $ 13.94M |
| Gross Profit | $ 26.12M | $ 28.27M | $ 19.71M | $ 14.04M | $ 10.57M |
| Operating Income | $ 266.00K | $ -2.46M | $ -3.02M | $ 575.00K | $ 550.00K |
| EBITDA | $ 6.08M | $ 2.77M | $ 2.36M | $ 3.61M | $ 2.35M |
| Net Income | $ 97.00K | $ -1.70M | $ -1.75M | $ 724.00K | $ 561.00K |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 7.34M | $ 12.74M | $ 16.67M | $ 19.84M | $ 19.68M |
| Total Assets | $ 50.01M | $ 48.62M | $ 46.34M | $ 48.26M | $ 45.01M |
| Total Debt | $ 1.15M | $ 1.06M | $ 1.21M | $ 1.33M | $ 1.56M |
| Net Debt | $ -6.19M | $ -11.68M | $ -15.46M | $ -18.51M | $ -18.11M |
| Total Liabilities | $ 9.53M | $ 8.76M | $ 5.56M | $ 5.74M | $ 4.36M |
| Stockholders' Equity | $ 40.48M | $ 39.86M | $ 40.79M | $ 42.51M | $ 40.65M |
| Cash Flow | |||||
| Free Cash Flow | $ 1.43M | $ -3.98M | $ -3.54M | $ 278.00K | $ -5.03M |
| Operating Cash Flow | $ 1.50M | $ 651.00K | $ 1.31M | $ 5.10M | $ 570.00K |
| Investing Cash Flow | $ -6.45M | $ -4.03M | $ -4.21M | $ -4.87M | $ -5.60M |
| Financing Cash Flow | $ -333.00K | $ -64.00K | $ -239.00K | $ -132.00K | $ -270.00K |
Currency in GBP